drugset / Trial / NCT06090799
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3032 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a single-center, double-blind, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SHR-3032 in healthy adults.
Timeline
- Start
- 2023-11-29
- Primary completion
- 2024-03-28
- Completion
- 2024-04-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR-3032 | Unknown | — | Intravenous |